These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 30409733)

  • 1. Cardiac contractility modulation treatment in patients with symptomatic heart failure despite optimal medical therapy and cardiac resynchronization therapy (CRT).
    Kuschyk J; Nägele H; Heinz-Kuck K; Butter C; Lawo T; Wietholt D; Roeger S; Gutterman D; Burkhoff D; Rousso B; Borggrefe M
    Int J Cardiol; 2019 Feb; 277():173-177. PubMed ID: 30409733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical effects of long-term cardiac contractility modulation (CCM) in subjects with heart failure caused by left ventricular systolic dysfunction.
    Müller D; Remppis A; Schauerte P; Schmidt-Schweda S; Burkhoff D; Rousso B; Gutterman D; Senges J; Hindricks G; Kuck KH
    Clin Res Cardiol; 2017 Nov; 106(11):893-904. PubMed ID: 28685207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized comparison of 5 versus 12 hours per day of cardiac contractility modulation treatment for heart failure patients: A preliminary report.
    Kloppe A; Mijic D; Schiedat F; Bogossian H; Mügge A; Rousso B; Lemke B
    Cardiol J; 2016; 23(1):114-9. PubMed ID: 26503077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits of left ventricular endocardial pacing comparing failed implants and prior non-responders to conventional cardiac resynchronization therapy: A subanalysis from the ALSYNC study.
    Biffi M; Defaye P; Jaïs P; Ruffa F; Leclercq C; Gras D; Yang Z; Gerritse B; Ziacchi M; Morgan JM;
    Int J Cardiol; 2018 May; 259():88-93. PubMed ID: 29579617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure.
    Borggrefe MM; Lawo T; Butter C; Schmidinger H; Lunati M; Pieske B; Misier AR; Curnis A; Böcker D; Remppis A; Kautzner J; Stühlinger M; Leclerq C; Táborsky M; Frigerio M; Parides M; Burkhoff D; Hindricks G
    Eur Heart J; 2008 Apr; 29(8):1019-28. PubMed ID: 18270213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac contractility modulation: first experience in heart failure patients with reduced ejection fraction and permanent atrial fibrillation.
    Röger S; Schneider R; Rudic B; Liebe V; Stach K; Schimpf R; Borggrefe M; Kuschyk J
    Europace; 2014 Aug; 16(8):1205-9. PubMed ID: 24706089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of left ventricular reverse remodeling induced by cardiac contractility modulation and cardiac resynchronization therapy in heart failure patients with different QRS durations.
    Zhang Q; Chan YS; Liang YJ; Fang F; Lam YY; Chan CP; Lee AP; Chan KC; Wu EB; Yu CM
    Int J Cardiol; 2013 Aug; 167(3):889-93. PubMed ID: 22330007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hospital-based and telemonitoring guided home-based training programs: effects on exercise tolerance and quality of life in patients with heart failure (NYHA class III) and cardiac resynchronization therapy. A randomized, prospective observation.
    Smolis-Bąk E; Dąbrowski R; Piotrowicz E; Chwyczko T; Dobraszkiewicz-Wasilewska B; Kowalik I; Kazimierska B; Jędrzejczyk B; Smolis R; Gepner K; Maciąg A; Sterliński M; Szwed H
    Int J Cardiol; 2015 Nov; 199():442-7. PubMed ID: 26276068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and survival in patients with cardiac contractility modulation: long-term single center experience in 81 patients.
    Kuschyk J; Roeger S; Schneider R; Streitner F; Stach K; Rudic B; Weiß C; Schimpf R; Papavasilliu T; Rousso B; Burkhoff D; Borggrefe M
    Int J Cardiol; 2015 Mar; 183():76-81. PubMed ID: 25662055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonexcitatory, cardiac contractility modulation electrical impulses: feasibility study for advanced heart failure in patients with normal QRS duration.
    Neelagaru SB; Sanchez JE; Lau SK; Greenberg SM; Raval NY; Worley S; Kalman J; Merliss AD; Krueger S; Wood M; Wish M; Burkhoff D; Nademanee K
    Heart Rhythm; 2006 Oct; 3(10):1140-7. PubMed ID: 17018340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triple-site pacing for cardiac resynchronization in permanent atrial fibrillation: follow-up results from a prospective observational study.
    Marques P; Nobre Menezes M; Lima da Silva G; Guimarães T; Bernardes A; Cortez-Dias N; Carpinteiro L; de Sousa J; Pinto FJ
    Europace; 2018 Jun; 20(6):986-992. PubMed ID: 28430960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
    Linde C; Gold MR; Abraham WT; St John Sutton M; Ghio S; Cerkvenik J; Daubert C;
    Eur Heart J; 2013 Sep; 34(33):2592-9. PubMed ID: 23641006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy.
    Zile MR; Abraham WT; Weaver FA; Butter C; Ducharme A; Halbach M; Klug D; Lovett EG; Müller-Ehmsen J; Schafer JE; Senni M; Swarup V; Wachter R; Little WC
    Eur J Heart Fail; 2015 Oct; 17(10):1066-74. PubMed ID: 26011593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac resynchronization therapy in chronic heart failure with moderately reduced left ventricular ejection fraction: Lessons from the Multicenter InSync Randomized Clinical Evaluation MIRACLE EF study.
    Linde C; Curtis AB; Fonarow GC; Lee K; Little W; Tang A; Levya F; Momomura S; Manrodt C; Bergemann T; Cowie MR
    Int J Cardiol; 2016 Jan; 202():349-55. PubMed ID: 26426276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac resynchronization therapy reduces T-wave alternans in patients with heart failure.
    Hua W; Chen K; Zhou X; Dai Y; Chen R; Wang J; Ding L; Liu Z; Feng T; Yu J; Cheng J; Liu C; Zhang S
    Europace; 2015 Feb; 17(2):281-8. PubMed ID: 25398405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of ejection fraction on the clinical response to cardiac resynchronization therapy in mild heart failure.
    Linde C; Daubert C; Abraham WT; St John Sutton M; Ghio S; Hassager C; Herre JM; Bergemann TL; Gold MR;
    Circ Heart Fail; 2013 Nov; 6(6):1180-9. PubMed ID: 24014828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac resynchronization therapy in patients with minimal heart failure: a systematic review and meta-analysis.
    Adabag S; Roukoz H; Anand IS; Moss AJ
    J Am Coll Cardiol; 2011 Aug; 58(9):935-41. PubMed ID: 21851882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of multidisciplinary cardiac rehabilitation on the response to cardiac resynchronization therapy.
    Martens P; Jacobs G; Dupont M; Mullens W
    Cardiovasc Ther; 2018 Dec; 36(6):e12467. PubMed ID: 30239134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study.
    Hsu JC; Solomon SD; Bourgoun M; McNitt S; Goldenberg I; Klein H; Moss AJ; Foster E;
    J Am Coll Cardiol; 2012 Jun; 59(25):2366-73. PubMed ID: 22698490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac contractility modulation improves long-term survival and hospitalizations in heart failure with reduced ejection fraction.
    Anker SD; Borggrefe M; Neuser H; Ohlow MA; Röger S; Goette A; Remppis BA; Kuck KH; Najarian KB; Gutterman DD; Rousso B; Burkhoff D; Hasenfuss G
    Eur J Heart Fail; 2019 Sep; 21(9):1103-1113. PubMed ID: 30652394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.